论文部分内容阅读
2012年4月,美国FDA批准将Novo Nordisk公司的地特胰岛素注射剂(insulin detemir/Levemir)的妊娠安全性分类自C类更改为B类。这意味着尽管动物生殖实验显示对胎儿有不良影响,但在人体中的研究证实地特胰岛素不会提高对胎儿损害的风险,故可安全地用于控制妊娠期糖尿病妇女的血糖水平。地特胰岛素是FDA迄
In April 2012, the U.S. FDA approved a change of classification of pregnancy safety for Novo Nordisk’s insulin detemir / Levemir from Category C to Category B. This means that while animal reproductive experiments have shown to have adverse effects on the fetus, studies in humans confirm that insulin detemir does not increase the risk of fetal damage and is therefore safe to use to control blood glucose levels in women with gestational diabetes. Dextrose is FDA until